Last reviewed · How we verify

D064, D702, placebo of D660

Chong Kun Dang Pharmaceutical · Phase 3 active Small molecule

D064, D702, placebo of D660 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 3 development. Also known as: D064, D702 are consisted of antihypertensive agent..

This drug is a small molecule.

At a glance

Generic nameD064, D702, placebo of D660
Also known asD064, D702 are consisted of antihypertensive agent.
SponsorChong Kun Dang Pharmaceutical
ModalitySmall molecule
PhasePhase 3

Mechanism of action

The exact mechanism of action is not well-documented.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about D064, D702, placebo of D660

What is D064, D702, placebo of D660?

D064, D702, placebo of D660 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.

How does D064, D702, placebo of D660 work?

This drug is a small molecule.

Who makes D064, D702, placebo of D660?

D064, D702, placebo of D660 is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).

Is D064, D702, placebo of D660 also known as anything else?

D064, D702, placebo of D660 is also known as D064, D702 are consisted of antihypertensive agent..

What development phase is D064, D702, placebo of D660 in?

D064, D702, placebo of D660 is in Phase 3.

Related